Form 8-K - Current report:
SEC Accession No. 0000950170-24-108465
Filing Date
2024-09-20
Accepted
2024-09-20 17:00:49
Documents
11
Period of Report
2024-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eldn-20240920.htm   iXBRL 8-K 43299
  Complete submission text file 0000950170-24-108465.txt   157343

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eldn-20240920.xsd EX-101.SCH 24851
13 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20240920_htm.xml XML 4703
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 241314018
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)